|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.0240 USD | +9.09% |
|
+20.00% | -60.91% |
| 06-02 | CV Sciences, Inc. - Shareholder/Analyst Call | |
| 05-14 | CV Sciences, Inc., Q1 2026 Earnings Call, May 14, 2026 |
| Market Cap | 4.9M 4.29M 3.96M 3.7M 6.95M 462M 7.09M 47.55M 18.4M 228M 18.38M 17.98M 791M | P/E 2024 |
-2.48x | P/E 2025 | -11.8x |
|---|---|---|---|---|---|
| Enterprise Value | 6.61M 5.8M 5.35M 5M 9.38M 624M 9.58M 64.24M 24.86M 308M 24.83M 24.29M 1.07B | EV / Sales 2024 |
0.42x | EV / Sales 2025 | 0.95x |
| Free-Float |
92.21% | Yield 2024 * |
-
| Yield 2025 | - |
Last Transcript: CV Sciences, Inc.
| 1 day | +9.09% | ||
| 1 week | +20.00% | ||
| Current month | -12.41% | ||
| 1 month | -10.45% | ||
| 3 months | -28.36% | ||
| 6 months | -49.58% | ||
| Current year | -60.91% |
| 1 week | 0.02 | 0.02 | |
| 1 month | 0.02 | 0.03 | |
| Current year | 0.02 | 0.1 | |
| 1 year | 0.02 | 0.1 | |
| 3 years | 0.02 | 0.1 | |
| 5 years | 0.02 | 0.4 | |
| 10 years | 0.02 | 9.2 |
| Manager | Title | Age | Since |
|---|---|---|---|
Joseph Dowling
CEO | Chief Executive Officer | 68 | 2018-05-30 |
Joerg Grasser
DFI | Director of Finance/CFO | 51 | 2019-03-14 |
| Director | Title | Age | Since |
|---|---|---|---|
Joseph Dowling
BRD | Director/Board Member | 68 | 2018-05-30 |
Jamie Corroon
BRD | Director/Board Member | 56 | 2022-07-20 |
William McCorkle
BRD | Director/Board Member | 58 | 2022-10-20 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 25-02-17 | Free | Chief Executive Officer | 3,000,000 | 1.6281% | ||
| 25-02-17 | Free | Chief Financial Officer | 2,350,000 | 1.2753% | ||
| 25-02-17 | Free | Director | 500,000 | 0.2714% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +9.09% | +20.00% | -40.00% | -41.46% | 4.9M | ||
| +7.13% | +9.97% | +55.80% | +163.38% | 1,077B | ||
| +3.99% | +11.50% | +67.09% | +56.27% | 613B | ||
| +4.20% | +17.03% | +38.97% | +91.19% | 448B | ||
| +0.49% | +4.85% | +28.17% | +22.04% | 332B | ||
| -0.35% | +7.14% | +40.70% | +26.73% | 293B | ||
| -0.46% | +4.17% | +30.29% | +40.58% | 286B | ||
| -1.13% | +4.28% | -28.84% | -41.36% | 215B | ||
| +1.56% | +6.14% | +29.30% | +61.91% | 193B | ||
| +3.26% | +3.33% | +15.55% | +67.87% | 159B | ||
| Average | +0.64% | +9.63% | +23.70% | +44.71% | 361.61B | |
| Weighted average by Cap. | +0.20% | +9.65% | +41.64% | +80.74% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 15.7M 13.77M 12.69M 11.88M 22.28M 1.48B 22.75M 153M 59.03M 732M 58.97M 57.68M 2.54B | 13.79M 12.09M 11.14M 10.43M 19.56M 1.3B 19.97M 134M 51.83M 643M 51.78M 50.65M 2.23B |
| Net income | -2.39M -2.1M -1.93M -1.81M -3.4M -226M -3.47M -23.26M -9M -112M -8.99M -8.79M -387M | -958K -840K -774K -725K -1.36M -90.37M -1.39M -9.31M -3.6M -44.66M -3.6M -3.52M -155M |
| Net Debt | 325K 285K 263K 246K 461K 30.66M 471K 3.16M 1.22M 15.15M 1.22M 1.19M 52.54M | 1.72M 1.51M 1.39M 1.3M 2.44M 162M 2.49M 16.69M 6.46M 80.1M 6.45M 6.31M 278M |
Employees
43
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-06-26 | US$0.0240 | +9.09% | 1,840,006 |
| 26-06-25 | US$0.0220 | 0.00% | 1,634,141 |
| 26-06-24 | US$0.0220 | +5.90% | 336,634 |
| 26-06-23 | US$0.0208 | -7.67% | 862,510 |
- Stock Market
- Stocks
- CVSI Stock
Select your edition
All financial news and data tailored to specific country editions

















